News | May 25, 2023
Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
This is the second US FDA GMP inspection of this facility within one year
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
India’s efforts are aimed at boosting health at the last mile
Subscribe To Our Newsletter & Stay Updated
